Literature DB >> 33407626

Combined Lycium babarum polysaccharides and C-phycocyanin increase gastric Bifidobacterium relative abundance and protect against gastric ulcer caused by aspirin in rats.

Shu-Yu Hsieh1, Yu Zhi Lian1, I-Hsuan Lin2, Yu-Chen Yang3, Alexey A Tinkov4,5, Anatoly V Skalny4,5, Jane C-J Chao6,7,8.   

Abstract

BACKGROUND: Non-steroidal anti-inflammatory drugs such as aspirin are used for the treatment of cardiovascular disease. Chronic use of low-dose aspirin is associated with the occurrence of gastric ulcer. The aim of this study was to investigate the healing potential of Lycium barbarum polysaccharides (LBP) from Chinese Goji berry and C-phycocyanin (CPC) from Spirulina platensis on gastric ulcer in rats.
METHODS: Male Sprague-Dawley rats were divided into five groups: normal, aspirin (700 mg/kg bw), LBP (aspirin + 100 mg/kg bw/d LBP), CPC (aspirin + 50 mg/kg bw/d CPC), and MIX (aspirin + 50 mg/kg bw/d LBP + 25 mg/kg bw/d CPC) groups. Gastric ulcer was developed by daily oral feeding of aspirin for 8 weeks. Treatments were given orally a week before ulcer induction for 9 weeks.
RESULTS: The MIX group elevated gastric cyclooxygenase-1, prostaglandin E2, and total nitrite and nitrate levels by 139%, 86%, and 66%, respectively, compared with the aspirin group (p < 0.05). Moreover, the MIX group reduced lipid peroxides malondialdehyde levels by 78% (p < 0.05). The treatment of LBP and/or CPC increased gastric Bifidobacterium relative abundance by 2.5-4.0 times compared with the aspirin group (p < 0.05).
CONCLUSIONS: We conclude that combined LBP and CPC enhance gastroprotective factors, inhibit lipid peroxidation, and increase gastric Bifidobacterium relative abundance. Combined LBP and CPC have protective potential against gastric ulcer caused by aspirin in rats.

Entities:  

Keywords:  Aspirin; C-phycocyanin; Gastric ulcer; Lycium barbarum polysaccharides; Microbiota

Year:  2021        PMID: 33407626     DOI: 10.1186/s12986-020-00538-9

Source DB:  PubMed          Journal:  Nutr Metab (Lond)        ISSN: 1743-7075            Impact factor:   4.169


  59 in total

1.  Prevalence and risk factors of asymptomatic peptic ulcer disease in Taiwan.

Authors:  Fu-Wei Wang; Ming-Shium Tu; Guang-Yuan Mar; Hung-Yi Chuang; Hsien-Chung Yu; Lung-Chih Cheng; Ping-I Hsu
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

Review 2.  Current roles of nitric oxide in gastrointestinal disorders.

Authors:  C H Cho
Journal:  J Physiol Paris       Date:  2001 Jan-Dec

3.  Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.

Authors:  Akiko Tanaka; Shoko Hase; Tohru Miyazawa; Ryoko Ohno; Koji Takeuchi
Journal:  J Pharmacol Exp Ther       Date:  2002-12       Impact factor: 4.030

4.  Astragaloside IV protects rat gastric mucosa against aspirin-induced damage.

Authors:  Dan-Dan Fan; Shan Lin; Yan-Ping Song; Ze-Yu Wang; Bo Liu; Sai-Nan Gao; Yu-Hua Fan; Shan Zhu; Sen Li; Lei Jiang
Journal:  Int Immunopharmacol       Date:  2016-11-02       Impact factor: 4.932

Review 5.  Systematic review of peptic ulcer disease incidence rates: do studies without validation provide reliable estimates?

Authors:  Kueiyu Joshua Lin; Luis A García Rodríguez; Sonia Hernández-Díaz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2011-05-27       Impact factor: 2.890

6.  Immunomodulatory activity of fucoidan against aspirin-induced gastric mucosal damage in rats.

Authors:  Hanumantha Rao Balaji Raghavendran; Periasamy Srinivasan; Sathyanath Rekha
Journal:  Int Immunopharmacol       Date:  2010-11-26       Impact factor: 4.932

7.  A prospective study of risk for peptic ulcer disease in Seventh-Day Adventists.

Authors:  J H Kurata; A N Nogawa; D E Abbey; F Petersen
Journal:  Gastroenterology       Date:  1992-03       Impact factor: 22.682

8.  Epidemiology of Upper Gastrointestinal Damage Associated with Low-Dose Aspirin.

Authors:  Ping-I Hsu; Tzung-Jiun Tsai
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

9.  Prevalence and incidence of peptic ulcer disease in a Danish County--a prospective cohort study.

Authors:  S J Rosenstock; T Jørgensen
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

Review 10.  Peptic-ulcer disease.

Authors:  Francis K L Chan; W K Leung
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321

View more
  4 in total

1.  Dietary Supplementation with Goji Berries (Lycium barbarum) Modulates the Microbiota of Digestive Tract and Caecal Metabolites in Rabbits.

Authors:  Paola Cremonesi; Giulio Curone; Filippo Biscarini; Elisa Cotozzolo; Laura Menchetti; Federica Riva; Maria Laura Marongiu; Bianca Castiglioni; Olimpia Barbato; Albana Munga; Marta Castrica; Daniele Vigo; Majlind Sulce; Alda Quattrone; Stella Agradi; Gabriele Brecchia
Journal:  Animals (Basel)       Date:  2022-01-05       Impact factor: 2.752

Review 2.  Recent Studies on Berry Bioactives and Their Health-Promoting Roles.

Authors:  Beyza Vahapoglu; Ezgi Erskine; Busra Gultekin Subasi; Esra Capanoglu
Journal:  Molecules       Date:  2021-12-24       Impact factor: 4.411

3.  Lycium barbarum Polysaccharides as Antibiotic Substitutes Improve Growth Performance, Serum Immunity, Antioxidant Status, and Intestinal Health for Weaned Piglets.

Authors:  Yexin Yin; Fang Wang; Mei Yang; Bie Tan; Yulong Yin; Jiashun Chen; Zhe Yang
Journal:  Front Microbiol       Date:  2022-02-25       Impact factor: 5.640

4.  Lycium barbarum Polysaccharide Regulates the Lipid Metabolism and Alters Gut Microbiota in High-Fat Diet Induced Obese Mice.

Authors:  Hui Xia; Beijia Zhou; Jing Sui; Wenqing Ma; Shaokang Wang; Ligang Yang; Guiju Sun
Journal:  Int J Environ Res Public Health       Date:  2022-09-24       Impact factor: 4.614

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.